Literature DB >> 12014794

Bone mineral density in male adolescents with anorexia nervosa.

Josefina Castro1, Josep Toro, Luisa Lazaro, Francesca Pons, Irene Halperin.   

Abstract

OBJECTIVES: To determine the percentage of male adolescent patients with abnormal bone mineral density (BMD), to identify the variables related to BMD loss, and to study BMD change after follow-up.
METHOD: Dual-energy-x-ray absorptiometry tests at the lumbar spine (L2-L4) and the femoral neck were administered in 20 male adolescents with anorexia nervosa (treated from 1997 until 2000 at the Department of Child and Adolescent Psychiatry and Psychology of the Hospital Clinic Universitari in Barcelona). Examinations were repeated in 15 patients after a follow-up of 6 to 24 months.
RESULTS: Thirty-five percent of patients had osteopenia at the lumbar spine and femoral neck. The following variables were related to osteopenia: >12 months' duration of anorexia (p = .003), <3 hours/week of physical activity (p = .009), and calcium intake <600 mg/day (p = .015). In a stepwise logistic regression analysis to predict spinal BMD with the three variables mentioned above, only months of duration entered in the equation (beta = 3.5, SE = 1.3, p = .008) and correctly classified 85% of patients. At the follow-up, patients with only partial weight recovery had a BMD loss of 3.2% at lumbar spine and 6.4% at femoral neck, whereas patients with total weight recovery had an increase of 7.8% at lumbar spine and 6.7% at femoral neck.
CONCLUSIONS: The risk of osteopenia in male adolescents with anorexia of more than 12 months' duration is high. In patients with total weight recovery, BMD increase is higher than normal.

Entities:  

Mesh:

Year:  2002        PMID: 12014794     DOI: 10.1097/00004583-200205000-00019

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  18 in total

Review 1.  State of the art systematic review of bone disease in anorexia nervosa.

Authors:  Madhusmita Misra; Neville H Golden; Debra K Katzman
Journal:  Int J Eat Disord       Date:  2015-08-27       Impact factor: 4.861

2.  A 2-year prospective study of bone metabolism and bone mineral density in adolescents with anorexia nervosa.

Authors:  C Mika; K Holtkamp; M Heer; R W Günther; B Herpertz-Dahlmann
Journal:  J Neural Transm (Vienna)       Date:  2007-08-06       Impact factor: 3.575

3.  Hip structural analysis in adolescent boys with anorexia nervosa and controls.

Authors:  Madhusmita Misra; Debra K Katzman; Hannah Clarke; Deirdre Snelgrove; Kathryn Brigham; Karen K Miller; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2013-05-07       Impact factor: 5.958

4.  Update on the female athlete triad.

Authors:  Michelle T Barrack; Kathryn E Ackerman; Jenna C Gibbs
Journal:  Curr Rev Musculoskelet Med       Date:  2013-06

Review 5.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

Review 6.  Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities.

Authors:  D J Howgate; S M Graham; A Leonidou; N Korres; E Tsiridis; E Tsapakis
Journal:  Osteoporos Int       Date:  2012-08-09       Impact factor: 4.507

Review 7.  Anorexia nervosa, obesity and bone metabolism.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Pediatr Endocrinol Rev       Date:  2013-09

8.  Anorexia Nervosa and Bone.

Authors:  Melanie Schorr; Anne Klibanski
Journal:  Curr Opin Endocr Metab Res       Date:  2018-01-31

Review 9.  Neuroendocrine consequences of anorexia nervosa in adolescents.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Endocr Dev       Date:  2009-11-24

10.  Bone mineral density in partially recovered early onset anorexic patients - a follow-up investigation.

Authors:  Ulrike Me Schulze; Simone Schuler; Dieter Schlamp; Peter Schneider; Claudia Mehler-Wex
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2010-07-08       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.